Martínez-Urbistondo, M.; Gutiérrez-Rojas, Á.; Andrés, A.; Gutiérrez, I.; Escudero, G.; García, S.; Gutiérrez, A.; Sánchez, E.; Herráiz, J.; De La Fuente, S.;
et al. Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients. J. Clin. Med. 2021, 10, 3595.
https://doi.org/10.3390/jcm10163595
AMA Style
Martínez-Urbistondo M, Gutiérrez-Rojas Á, Andrés A, Gutiérrez I, Escudero G, García S, Gutiérrez A, Sánchez E, Herráiz J, De La Fuente S,
et al. Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients. Journal of Clinical Medicine. 2021; 10(16):3595.
https://doi.org/10.3390/jcm10163595
Chicago/Turabian Style
Martínez-Urbistondo, María, Ángela Gutiérrez-Rojas, Ane Andrés, Isabel Gutiérrez, Gabriela Escudero, Sonia García, Andrea Gutiérrez, Enrique Sánchez, Jesús Herráiz, Sara De La Fuente,
and et al. 2021. "Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients" Journal of Clinical Medicine 10, no. 16: 3595.
https://doi.org/10.3390/jcm10163595
APA Style
Martínez-Urbistondo, M., Gutiérrez-Rojas, Á., Andrés, A., Gutiérrez, I., Escudero, G., García, S., Gutiérrez, A., Sánchez, E., Herráiz, J., De La Fuente, S., Callejas, A., De Mendoza, C., & Moreno-Torres, V.
(2021). Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients. Journal of Clinical Medicine, 10(16), 3595.
https://doi.org/10.3390/jcm10163595
